According to SPER Market Research, the Hydrocolloid Dressing Market estimated to reach USD 2.12 billion by 2030 with a CAGR of 5.5%.
Accidents frequently cause severe bleeding and other injuries, demanding immediate medical attention and surgical procedures to provide patients with relief right away. Because hydrocolloid dressings are efficient for both acute and chronic wounds of various thicknesses, the prevalence of both chronic and acute wounds is thus anticipated to increase.
In lower discharge or necrotic tissue, they promote autolytic debridement. For the treatment of pressure injuries, they adhere successfully to high-friction regions such as the heels and the sacrum. In order to reduce pressure injuries caused by medical devices, hydrocolloid dressings are also used as protective dressings on intubated patients in the ICU. Abrasions and small burns are also treated with them. The aforementioned factors are hence driving the expansion of the hydrocolloid dressing market. Due to its absorbency and ability to provide a barrier of protection over the skin, hydrocolloid technology has long been used in advanced wound care.
The use of additives and recent breakthroughs in hydrocolloid technology has considerably improved patient care. The production of materials using contemporary hydrocolloid extruders is more efficient, reliable, and waste-free. The creation of hybrid materials that mix hydrocolloid and acrylic PSA is another development in the hydrocolloid family. One such development is the exclusive Thin Absorbent Skin Adhesive from Avery Dennison Medical (TASA).
A variety of carrier materials, including polyurethane films and nonwovens, can be coated with adhesive. Standard hydrocolloid adhesives typically range in thickness from 0.3 to 1.0 mm, but TASA is only 0.1 mm thick. Additionally, it encourages absorbency and breathability. Wear periods of up to seven days are possible because of these exceptional fluid-handling characteristics. As a result, these improvements and advancements have created a wide range of new opportunities for a better patient experience, boosting the industry. Using a hydrocolloid dressing for advanced wound care has a number of additional benefits, such as high durability, quicker healing, reduced discomfort, a lower risk of infection, and adherence exclusively to surrounding skin. In addition, hydrocolloids are inexpensive, versatile, and waterproof. When wounds are partially healed or newly healed skin is still intact, they can make an excellent protective barrier to shield the area from potential surface harm. Because of the mentioned advantages offered by hydrocolloid dressings, their use is therefore expected to increase during the projection period.
Impact of COVID-19 on the Global Hydrocolloid Dressing Market:
Doctors and other front-line personnel have greatly benefited from the hydrocolloid dressing's ability to avoid facial pressure and facial markings when wearing medical protective equipment during the COVID-19 epidemic. A layer of semi-permeable hydrocolloid, commonly used for wound healing, can be found inside a film or foam pad that clings to the skin. This is accomplished by using a hydrocolloid dressing. Following the trimming of the hydrocolloid dressing, the adhesive dressing is applied to the skin of the nasal dorsum, cheeks, and forehead, covering the region where the mask and safety goggles would sit. This has a substantial impact on the market expansion of hydrocolloids in the pharmaceutical industry.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2019-2030 |
| Base year considered | 2021 |
| Forecast period | 2022-2030 |
| Segments covered | By Raw Material, By Application, By Product, By End-User
|
| Geographies covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | B. Braun Melsungen AG, Cardinal Health, Convatec Inc., Covalon Technologies Ltd., Coloplast Corp., Dermarite Industries LLC., Johnson & Johnson, Lohmann & Rauscher, Medline Industries Inc., Paul Hartmann AG, Smith & Nephew, 3M.
|
Global Hydrocolloid Dressing Market, By Raw Material:
Based on the Raw Material, Global Hydrocolloid Dressing Market is segmented as; Synthetic, Natural, Semi-Synthetic.
Global Hydrocolloid Dressing Market, By Application:
Based on the Application, Global Hydrocolloid Dressing Market is segmented as; Pressure Ulcer, Venous leg Ulcer, Diabetic Ulcer, Burn Wounds, Others.
Global Hydrocolloid Dressing Market, By Product:
Based on the Product, Global Hydrocolloid Dressing Market is segmented as; Sheet Dressings, Amorphous, Impregnated Dressings.
Global Hydrocolloid Dressing Market, By End-User:
Based on the End-User, Global Hydrocolloid Dressing Market is segmented as; Homecare Settings, Hospitals & Clinics, Others.
Global Hydrocolloid Dressing Market, By Regions:
The Global Hydrocolloid Dressing Market is majorly driven by North-America. During the projected period, North-America is anticipated to have the quickest rate of growth in the worldwide Hydrocolloid Dressing Market.
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Hydrocolloid Dressing Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Global Hydrocolloid Dressing Market , By Raw Material, 2019-2030 (USD Million)
6.1. Synthetic
6.2. Natural
6.3. Semi-Synthetic
7. Global Hydrocolloid Dressing Market , By Application, 2019-2030 (USD Million)
7.1. Pressure Ulcer
7.2. Venous leg Ulcer
7.3. Diabetic Ulcer
7.4. Burn Wounds
7.5. Others
8. Global Hydrocolloid Dressing Market , By Product, 2019-2030 (USD Million)
8.1. Sheet Dressings
8.2. Amorphous
8.3. Impregnated Dressings
9. Global Hydrocolloid Dressing Market , By End-User, 2019-2030 (USD Million)
9.1. Homecare Settings
9.2. Hospitals & Clinics
9.3. Others
10. Global Hydrocolloid Dressing Market , By Region , 2019-2030 (USD Million)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. Europe
10.2.1. Germany
10.2.2. United Kingdom
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia
10.3.5. South Korea
10.3.6. Rest of Asia-Pacific
10.4. South America
10.4.1. Brazil
10.4.2. Argentina
10.4.3. Rest of South America
10.5. Middle East & Africa
10.5.1. Kingdom of Saudi Arabia
10.5.2. United Arab Emirates
10.5.3. Rest of Middle East & Africa
11. Company Profiles11.1. B. Braun Melsungen AG
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. Cardinal Health
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. Convatec Inc.
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. Covalon Technologies Ltd.
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. Coloplast Corp.
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. Dermarite Industries LLC.
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. Johnson & Johnson
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. Lohmann & Rauscher
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Medline Industries Inc.
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Paul Hartmann AG
11.10.1. Company details
11.10.2. Financial outlook
11.10.3. Product summary
11.10.4. Recent developments
11.11. Smith & Nephew
11.11.1. Company details
11.11.2. Financial outlook
11.11.3. Product summary
11.11.4. Recent developments
11.12. 3M
11.12.1. Company details
11.12.2. Financial outlook
11.12.3. Product summary
11.12.4. Recent developments